1
|
Laidlaw GF: Nesidioblastoma, the islet
tumor of the pancreas. Am J Pathol. 14:125–134.5. 1938.PubMed/NCBI
|
2
|
García-Santos EP, Manzanares-Campillo Mdel
C, Padilla-Valverde D, Villarejo-Campos P, Gil-Rendo A,
Muñoz-Atienza V, Sánchez-García S, Puig-Rullán AM,
Rodríguez-Peralto JL and Martín-Fernández J: Nesidioblastosis. A
case of hyperplasia of the islets of Langerhans in the adult.
Pancreatology. 13:544–548. 2013.PubMed/NCBI View Article : Google Scholar
|
3
|
Klöppel G, Anlauf M, Raffel A, Perren A
and Knoefel WT: Adult diffuse nesidioblastosis: Genetically or
environmentally induced? Hum Pathol. 39:3–8. 2008.PubMed/NCBI View Article : Google Scholar
|
4
|
Yamada Y, Kitayama K, Oyachi M, Higuchi S,
Kawakita R, Kanamori Y and Yorifuji T: Nationwide survey of
endogenous hyperinsulinemic hypoglycemia in Japan (2017-2018):
Congenital hyperinsulinism, insulinoma, non-insulinoma
pancreatogenous hypoglycemia syndrome and insulin autoimmune
syndrome (Hirata's disease). J Diabetes Investig. 11:554–563.
2020.PubMed/NCBI View Article : Google Scholar
|
5
|
Anlauf M, Wieben D, Perren A, Sipos B,
Komminoth P, Raffel A, Kruse ML, Fottner C, Knoefel WT, Mönig H, et
al: Persistent hyperinsulinemic hypoglycemia in 15 adults with
diffuse nesidioblastosis: Diagnostic criteria, incidence, and
characterization of beta-cell changes. Am J Surg Pathol.
29:524–533. 2005.PubMed/NCBI View Article : Google Scholar
|
6
|
Witteles RM, Straus II FH, Sugg SL, Koka
MR, Costa EA and Kaplan EL: Adult-onset nesidioblastosis causing
hypoglycemia: An important clinical entity and continuing treatment
dilemma. Arch Surg. 136:656–663. 2001.PubMed/NCBI View Article : Google Scholar
|
7
|
Prasad V, Sainz-Esteban A, Arsenic R,
Plöckinger U, Denecke T, Pape UF, Pascher A, Kühnen P, Pavel M and
Blankenstein O: Role of (68)Ga somatostatin receptor PET/CT in the
detection of endogenous hyperinsulinaemic focus: An explorative
study. Eur J Nucl Med Mol Imaging. 43:1593–1600. 2016.PubMed/NCBI View Article : Google Scholar
|
8
|
Dravecka I and Lazurova I:
Nesidioblastosis in adults. Neoplasma. 61:252–256. 2014.PubMed/NCBI View Article : Google Scholar
|
9
|
Glaser B, Chiu KC, Anker R, Nestorowicz A,
Landau H, Ben-Bassat H, Shlomai Z, Kaiser N, Thornton PS, Stanley
CA, et al: Familial hyperinsulinism maps to chromosome 11p14-15.1,
30 cM centromeric to the insulin gene. Nat Genet. 7:185–188.
1994.PubMed/NCBI View Article : Google Scholar
|
10
|
Rumilla KM, Erickson LA, Service FJ, Vella
A, Thompson GB, Grant CS and Lloyd RV: Hyperinsulinemic
hypoglycemia with nesidioblastosis: Histologic features and growth
factor expression. Mod Pathol. 22:239–245. 2009.PubMed/NCBI View Article : Google Scholar
|
11
|
Dieterle MP, Husari A, Prozmann SN,
Wiethoff H, Stenzinger A, Röhrich M, Pfeiffer U, Kießling WR, Engel
H, Sourij H, et al: Diffuse, adult-onset
nesidioblastosis/non-insulinoma pancreatogenous hypoglycemia
syndrome (NIPHS): Review of the literature of a rare cause of
hyperinsulinemic hypoglycemia. Biomedicines.
11(1732)2023.PubMed/NCBI View Article : Google Scholar
|
12
|
Ahmed FW, Majeed MS and Kirresh O:
Non-Diabetic Hypoglycemia. In: StatPearls [Internet]. Treasure
Island (FL): StatPearls Publishing; 2023.
|
13
|
Geraghty M, Draman M, Moran D, Muldoon C,
Reynolds JV and Cullen MJ: Hypoglycaemia in an adult male: A
surprising finding in pursuit of insulinoma. Surgeon. 6:57–60.
2008.PubMed/NCBI View Article : Google Scholar
|
14
|
Starke A, Saddig C, Kirch B, Tschahargane
C and Goretzki P: Islet hyperplasia in adults: Challenge to
preoperatively diagnose non-insulinoma pancreatogenic hypoglycemia
syndrome. World J Surg. 30:670–679. 2006.PubMed/NCBI View Article : Google Scholar
|
15
|
Doi S, Yamada T, Kito Y, Obara S, Fujii Y,
Nishimura T, Kato T, Nakayama H, Tsutsumi M and Okamura R:
Adult-Onset Focal Nesidioblastosis With Nodular Formation Mimicking
Insulinoma. J Endocr Soc. 6(bvab185)2021.PubMed/NCBI View Article : Google Scholar
|
16
|
Mehrabi A, Fischer L, Hafezi M,
Dirlewanger A, Grenacher L, Diener MK, Fonouni H, Golriz M,
Garoussi C, Fard N, et al: A systematic review of localization,
surgical treatment options, and outcome of insulinoma. Pancreas.
43:675–686. 2014.PubMed/NCBI View Article : Google Scholar
|
17
|
Hu X, Li D, Wang R, Wang P and Cai J:
Comparison of the application of 18F-FDG and 68Ga-DOTATATE PET/CT
in neuroendocrine tumors: A retrospective study. Medicine
(Baltimore). 102(e33726)2023.PubMed/NCBI View Article : Google Scholar
|
18
|
Deroose CM, Hindié E, Kebebew E, Goichot
B, Pacak K, Taïeb D and Imperiale A: Molecular imaging of
gastroenteropancreatic neuroendocrine tumors: Current status and
future directions. J Nucl Med. 57:1949–1956. 2016.PubMed/NCBI View Article : Google Scholar
|
19
|
Kalff V, Iravani A, Akhurst T, Pattison
DA, Eu P, Hofman MS and Hicks RJ: Utility of
68Ga-DOTA-Exendin-4 positron emission
tomography-computed tomography imaging in distinguishing between
insulinoma and nesidioblastosis in patients with confirmed
endogenous hyperinsulinaemic hypoglycaemia. Intern Med J.
51:1657–1664. 2021.PubMed/NCBI View Article : Google Scholar
|
20
|
Antwi K, Hepprich M, Müller NA, Reubi JC,
Fani M, Rottenburger C, Nicolas G, Kaul F, Christ ER and Wild D:
Pitfalls in the detection of insulinomas with glucagon-like
peptide-1 receptor imaging. Clin Nucl Med. 45:e386–e392.
2020.PubMed/NCBI View Article : Google Scholar
|
21
|
Dauriz M, Maneschi C, Castelli C,
Tomezzoli A, Fuini A, Landoni L, Malleo G, Ferdeghini M, Bonora E
and Moghetti P: A case report of insulinoma relapse on background
nesidioblastosis: A rare cause of adult hypoglycemia. J Clin
Endocrinol Metab. 104:773–778. 2019.PubMed/NCBI View Article : Google Scholar
|
22
|
Arao T, Okada Y, Hirose A and Tanaka Y: A
rare case of adult-onset nesidioblastosis treated successfully with
diazoxide. Endocr J. 53:95–100. 2006.PubMed/NCBI View Article : Google Scholar
|
23
|
Demartin S, Goffette P, Christ E, Freitag
MT, Maiter D and Maria Furnica R: Adult-onset nesidioblastosis: A
challenging diagnosis revealed by glucagon-like-peptide-1 receptor
imaging. Endocrinol Diabetes Metab Case Rep. 2022:22–0325.
2022.PubMed/NCBI View Article : Google Scholar
|
24
|
Nagtegaal ID, Odze RD, Klimstra D, Paradis
V, Rugge M, Schirmacher P, Washington KM, Carneiro F and Cree IA:
WHO Classification of Tumours Editorial Board. The 2019 WHO
classification of tumours of the digestive system. Histopathology.
76:182–188. 2020.PubMed/NCBI View Article : Google Scholar
|